Brendel Financial Advisors LLC Buys Shares of 3,838 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Brendel Financial Advisors LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, HoldingsChannel.com reports. The firm bought 3,838 shares of the medical equipment provider’s stock, valued at approximately $2,003,000.

Other hedge funds have also added to or reduced their stakes in the company. Wealthspire Advisors LLC increased its stake in shares of Intuitive Surgical by 10.9% in the 2nd quarter. Wealthspire Advisors LLC now owns 1,145 shares of the medical equipment provider’s stock worth $509,000 after purchasing an additional 113 shares in the last quarter. Brown Brothers Harriman & Co. increased its stake in shares of Intuitive Surgical by 45.3% in the 2nd quarter. Brown Brothers Harriman & Co. now owns 2,228 shares of the medical equipment provider’s stock worth $991,000 after purchasing an additional 695 shares in the last quarter. Angeles Investment Advisors LLC purchased a new stake in shares of Intuitive Surgical in the 2nd quarter worth $221,000. Dimensional Fund Advisors LP increased its stake in shares of Intuitive Surgical by 10.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 572,934 shares of the medical equipment provider’s stock worth $254,872,000 after purchasing an additional 52,976 shares in the last quarter. Finally, One Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the 2nd quarter worth $790,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 0.2 %

ISRG opened at $538.88 on Wednesday. The firm has a market cap of $191.94 billion, a P/E ratio of 86.64, a P/E/G ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $355.17 and a 12 month high of $556.23. The stock has a 50-day moving average of $537.05 and a 200 day moving average of $496.50.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares in the company, valued at $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,788,899.12. This represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock worth $25,012,927 over the last 90 days. Company insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on ISRG shares. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Royal Bank of Canada lifted their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. BTIG Research lifted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Stifel Nicolaus lifted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.